JPMorgan Chase & Co’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $444K | Sell |
34,147
-128,656
| -79% | -$1.67M | ﹤0.01% | 4121 |
|
|
2025
Q1 | $4.11M | Buy |
162,803
+128,406
| +373% | +$3.24M | ﹤0.01% | 2803 |
|
|
2024
Q4 | $1.18M | Sell |
34,397
-158,113
| -82% | -$5.44M | ﹤0.01% | 3698 |
|
|
2024
Q3 | $9.52M | Buy |
192,510
+7,494
| +4% | +$370K | ﹤0.01% | 2189 |
|
|
2024
Q2 | $11.1M | Sell |
185,016
-125,944
| -41% | -$7.58M | ﹤0.01% | 2043 |
|
|
2024
Q1 | $16M | Sell |
310,960
-285,580
| -48% | -$14.7M | ﹤0.01% | 1830 |
|
|
2023
Q4 | $24.1M | Buy |
596,540
+44,975
| +8% | +$1.81M | ﹤0.01% | 1511 |
|
|
2023
Q3 | $15.4M | Buy |
551,565
+11,431
| +2% | +$319K | ﹤0.01% | 1676 |
|
|
2023
Q2 | $15.6M | Sell |
540,134
-25,372
| -4% | -$731K | ﹤0.01% | 1715 |
|
|
2023
Q1 | $9.43M | Buy |
565,506
+553,820
| +4,739% | +$9.24M | ﹤0.01% | 2047 |
|
|
2022
Q4 | $148K | Buy |
11,686
+434
| +4% | +$5.5K | ﹤0.01% | 4341 |
|
|
2022
Q3 | $135K | Buy |
11,252
+243
| +2% | +$2.92K | ﹤0.01% | 4342 |
|
|
2022
Q2 | $155K | Buy |
11,009
+2,782
| +34% | +$39.2K | ﹤0.01% | 4437 |
|
|
2022
Q1 | $102K | Buy |
8,227
+2,820
| +52% | +$35K | ﹤0.01% | 4738 |
|
|
2021
Q4 | $61K | Buy |
5,407
+1,362
| +34% | +$15.4K | ﹤0.01% | 5004 |
|
|
2021
Q3 | $51K | Buy |
+4,045
| New | +$51K | ﹤0.01% | 4956 |
|